A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

NCT02661815 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Company decided not to move forward with further accrual.

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma

Interventions

DRUG: Paclitaxel
DRUG: Ricolinostat
DRUG: Bevacizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]